Published in J Clin Oncol on January 01, 2005
Iodine-131 dose dependent gene expression in thyroid cancers and corresponding normal tissues following the Chernobyl accident. PLoS One (2012) 1.12
Differential gene expression triggered by highly cytotoxic alpha-emitter-immunoconjugates in gastric cancer cells. Invest New Drugs (2009) 0.91
Molecular genetics of testicular germ cell tumors. Am J Cancer Res (2012) 0.89
Iodine-131 dose-dependent gene expression: alterations in both normal and tumour thyroid tissues of post-Chernobyl thyroid cancers. Br J Cancer (2013) 0.86
Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis. Endocr Rev (2013) 0.85
Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors. Genome Res (2016) 0.75
Testicular cancer in two brothers of a quadruplet: a case report and a review of literature. Acta Med Litu (2017) 0.75
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol (2000) 8.08
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med (1984) 2.26
Organ sparing surgery for malignant germ cell tumor of the testis. J Urol (2001) 1.99
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
Preservation of regional myocardial function and myocardial oxygen tension during acute ischemia in pigs: comparison of selective synchronized suction and retroinfusion of coronary veins to synchronized coronary venous retroperfusion. J Am Coll Cardiol (1994) 1.39
[Prostate cancer centres / prostate centres--certified by DKG or DVPZ]. Aktuelle Urol (2009) 1.39
Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard. Eur Radiol (2013) 1.30
Comparison of established and emerging biodosimetry assays. Radiat Res (2013) 1.23
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group. J Clin Oncol (2001) 1.20
Laboratory intercomparison on the γ-H2AX foci assay. Radiat Res (2013) 1.12
Laboratory intercomparison of gene expression assays. Radiat Res (2013) 1.10
Laboratory intercomparison of the dicentric chromosome analysis assay. Radiat Res (2013) 1.05
Isolation and biological activity of aspidospermine and quebrachamine from an Aspidosperma tree source. J Pharm Biomed Anal (1994) 1.01
Gene expression comparisons performed for biodosimetry purposes on in vitro peripheral blood cellular subsets and irradiated individuals. Radiat Res (2012) 1.00
A radiation-induced gene signature distinguishes post-Chernobyl from sporadic papillary thyroid cancers. Radiat Res (2007) 0.99
Prognostic aspects, survival rate, and predisposing risk factors in patients with Fournier's gangrene and necrotizing soft tissue infections: evaluation of clinical outcome of 55 patients. Urol Int (2012) 0.97
Laboratory intercomparison of the cytokinesis-block micronucleus assay. Radiat Res (2013) 0.97
Eukaryotic initiation factor 3 p110 mRNA is overexpressed in testicular seminomas. Am J Pathol (2000) 0.96
[PREFERE - the German prostatic cancer study: questions and claims surrounding study initiation in January 2013]. Urologe A (2013) 0.95
[Intravesical migration of a polypropylene mesh implant 3 years after laparoscopic transperitoneal hernioplasty]. Urologe A (2002) 0.93
The search for biomarkers of metastatic seminoma. J Urol (2013) 0.90
Metanephric adenoma of the kidney: case report and review of the literature. Int Urol Nephrol (2005) 0.90
Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99). Int J Clin Pract (2006) 0.89
Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation. Br J Cancer (2001) 0.88
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial. Hum Gene Ther (2001) 0.88
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer. J Clin Oncol (2004) 0.87
[Familial synostosis of metacarpi IV and V]. Z Orthop Ihre Grenzgeb (1965) 0.87
Is macrosomia predictable, and are shoulder dystocia and birth trauma preventable? Obstet Gynecol (1996) 0.86
Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG). Ann Oncol (2005) 0.86
Evaluation of a structured report of functional prostate magnetic resonance imaging in patients with suspicion for prostate cancer or under active surveillance. Urol Int (2012) 0.85
[Clarification of tissue contamination in a suspected adenocarcinoma of the spermatic cord by microsatellite analysis]. Urologe A (2004) 0.84
Acute perforated neonatal appendicitis associated with chorioamnionitis. Eur J Pediatr Surg (2001) 0.84
Expression and function of the vitamin D receptor in malignant germ cell tumour of the testis. Anticancer Res (2012) 0.84
Immunogenicity of hepatitis B vaccine in preterm infants. Arch Dis Child Fetal Neonatal Ed (1998) 0.84
Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system. Rofo (2012) 0.84
Comparison of the abundance of 10 radiation-induced proteins with their differential gene expression in L929 cells. Int J Radiat Biol (2003) 0.83
[Bulbo-bulbar and bulbo-prostatic anastomosis of the urethra]. Urologe A (1998) 0.83
Management of complete ureteral replacement. Experiences and review of the literature. Scand J Urol Nephrol (1997) 0.83
Loss of heterozygosity, differentiation, and clonality in microdissected male germ cell tumours. J Pathol (1999) 0.83
Synthesis, testing, and characterization of a novel Nafion membrane with superior performance in photoassisted immobilized Fenton catalysis. Langmuir (2004) 0.81
Elevated human chorionic gonadotropin concentrations in the testicular vein and in peripheral venous blood in seminoma patients. An analysis of various parameters. Eur Urol (1997) 0.81
Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer. J Urol (1998) 0.81
Epithelioid sarcoma of the penis--a rare differential diagnosis of Peyronie's disease. Int J Impot Res (2003) 0.80
Expression and function of protein phosphatase PP2A in malignant testicular germ cell tumours. J Pathol (2007) 0.80
Success of intracytoplasmic sperm injection in couples with male and/or female chromosome aberrations. Hum Reprod (1997) 0.80
[Certified prostate cancer centers of the German Cancer Society : Current status 2 years after certification and future developments]. Urologe A (2010) 0.79
Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients. World J Urol (2012) 0.79
Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells. Urology (2003) 0.79
Long term results and morbidity of paraaortic compared with paraaortic and iliac adjuvant radiation in clinical stage I seminoma. Anticancer Res (2001) 0.79
[Complete resection of urothelial cancer metastases with curative intent]. Urologe A (2009) 0.79
Transcriptional profiling of transurethral resection samples provides insight into molecular mechanisms of hormone refractory prostate cancer. Prostate Cancer Prostatic Dis (2007) 0.79
Effect of increased environmental temperature on breathing patterns in preterm and term infants. J Perinatol (1998) 0.79
[Ablatio testis and enucleation resection]. Aktuelle Urol (2009) 0.79
Radiation-induced gene expression in MCF-7 cells. Int J Radiat Biol (2003) 0.79
Influence of high-frequency electromagnetic fields on different modes of cell death and gene expression. Int J Radiat Biol (2003) 0.79
[Standardised scoring of a multi-parametric 3-T MRI for a targeted MRI-guided prostate biopsy]. Urologe A (2012) 0.78
Intercomparison of apoptosis morphology with active DNA cleavage on single cells in vitro and on testis tumours. J Pathol (1998) 0.78
Increased autophagy in peripheral nerves may protect Wistar Ottawa Karlsburg W rats against neuropathy. Exp Neurol (2013) 0.78
[Metastases of germ cell tumors to the ENT area--a rare differential diagnosis of lymph node metastases in unknown primary tumor]. Laryngorhinootologie (1996) 0.78
Reconsidering Current Decorporation Strategies after Incorporation of Radionuclides. Health Phys (2016) 0.78
[Molecular pathogenesis and prognostic factors in testicular tumor]. Urologe A (1998) 0.77
Proteomic analysis of radiation-induced alterations in L929 cells. Folia Biol (Praha) (2003) 0.77
A unifying model for reconstructing radiosensitivity from micronucleus formation, apoptosis and abnormal morphology. Radiat Environ Biophys (2002) 0.77
[Radiation and burn trauma (combined injury). Considerations in surgical treatment]. Unfallchirurg (2001) 0.77
[Seminal vesicle sparing radical perineal prostatectomy]. Urologe A (2009) 0.77
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]. Urologe A (2003) 0.77
Human and mouse RAD17 genes: identification, localization, genomic structure and histological expression pattern in normal testis and seminoma. Hum Genet (1999) 0.77
[The modified ureterosigmoidostomy (Mainz pouch II) as a continent form of urinary diversion]. Urologe A (2004) 0.77
Prediction of metastatic status in non-seminomatous testicular cancer. World J Urol (2013) 0.77
Significance of apoptosis in metastasizing testis tumors. Urol Res (2003) 0.77
Apoptosis in human embryonal cell carcinoma: preliminary results. Urol Res (1999) 0.76
Topographic deformation patterns of knee cartilage after exercises with high knee flexion: an in vivo 3D MRI study using voxel-based analysis at 3T. Eur Radiol (2015) 0.76
[Urinary retention with ruptured fornix caused by a maggot. An autoerotic accident]. Urologe A (2005) 0.76
p53 immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder--a helpful parameter in guiding the decision for or against cystectomy? Eur J Cancer (2000) 0.76
Intercellular adhesion molecule-1: a consistent inflammatory marker of the cutaneous radiation reaction both in vitro and in vivo. Br J Dermatol (2006) 0.76
[Sclerosing Sertoli cell tumor of the testis: a rare tumor. Case report and review of the literature on the subtypes of Sertoli-cell tumor]. Urologe A (2007) 0.76
Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment. J Clin Oncol (1998) 0.76
[Chemotherapy for urothelial cancer of the bladder--update 2012]. Aktuelle Urol (2012) 0.76
[Long-term results of corpus cavernosum auto-injection therapy in treatment of patients with chronic erectile dysfunction]. Urologe A (1992) 0.76
Congenital cardiac fibroma: an unusual presentation. Eur J Pediatr (1982) 0.75
[Testicular loss due to hemorrhagic infarct in Tauber antegrade scrotal varicocele sclerotherapy]. Urologe A (1997) 0.75
A simple method of blood exchange in mice and its application to immunology. Immunology (1971) 0.75
Possible role of FDG-PET in the evaluation of urologic malignancies. Anticancer Res (1997) 0.75
Detection of hypoxia markers in the cerebellum after a traumatic frontal cortex injury: a human postmortem gene expression analysis. Int J Legal Med (2014) 0.75
Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy. Eur J Cancer (1995) 0.75
[Medizip surgical zipper: a new form of non-invasive wound closure with a surgical zipper]. Aktuelle Urol (2003) 0.75
[Adrenal gland metastasis of clear-cell renal cell carcinoma: a diagnostic problem in chemical-shift MRT imaging]. Rofo (2003) 0.75
[Steps in the primary immune response in vivo. II. The requirement for preformed specific antibody (author's transl)]. Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M (1974) 0.75
False negative testicular biopsy in an extragonadal germ cell tumour. Eur J Cancer (1994) 0.75
[Abnormalities of the urachus]. Aktuelle Urol (2003) 0.75
Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumors. Cancer (1994) 0.75
Extensive surgery in metastatic testicular cancer. Aktuelle Urol (2003) 0.75
[Gemcitabine in advanced bladder cancer]. Urologe A (2002) 0.75